Twin Lakes Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.21K | Hold |
1,957
| – | – | ﹤0.01% | 212 |
|
|
2025
Q1 | $2.86K | Hold |
1,957
| – | – | ﹤0.01% | 208 |
|
|
2024
Q4 | $4.17K | Hold |
1,957
| – | – | ﹤0.01% | 216 |
|
|
2024
Q3 | $5.48K | Hold |
1,957
| – | – | ﹤0.01% | 214 |
|
|
2024
Q2 | $4.56K | Hold |
1,957
| – | – | ﹤0.01% | 222 |
|
|
2024
Q1 | $8.75K | Hold |
1,957
| – | – | 0.01% | 210 |
|
|
2023
Q4 | $6.28K | Hold |
1,957
| – | – | ﹤0.01% | 218 |
|
|
2023
Q3 | $6.2K | Hold |
1,957
| – | – | ﹤0.01% | 225 |
|
|
2023
Q2 | $9.73K | Hold |
1,957
| – | – | 0.01% | 207 |
|
|
2023
Q1 | $9.67K | Hold |
1,957
| – | – | 0.01% | 205 |
|
|
2022
Q4 | $12.3K | Sell |
1,957
-1,020
| -34% | -$6.42K | 0.01% | 198 |
|
|
2022
Q3 | $32K | Hold |
2,977
| – | – | 0.03% | 158 |
|
|
2022
Q2 | $34K | Hold |
2,977
| – | – | 0.02% | 115 |
|
|
2022
Q1 | $27K | Buy |
2,977
+208
| +8% | +$1.89K | 0.02% | 179 |
|
|
2021
Q4 | $41K | Sell |
2,769
-203
| -7% | -$3.01K | 0.02% | 171 |
|
|
2021
Q3 | $76K | Sell |
2,972
-565
| -16% | -$14.4K | 0.04% | 125 |
|
|
2021
Q2 | $92K | Sell |
3,537
-756
| -18% | -$19.7K | 0.05% | 106 |
|
|
2021
Q1 | $152K | Buy |
+4,293
| New | +$152K | 0.09% | 90 |
|